Oriental Aromatics crosses INR 1,000 crore revenue in FY26
Oriental Aromatics Limited achieved a consolidated revenue of INR 1,030.8 crore in FY26, an 11% increase from the previous year, despite significant raw material inflation and pricing pressures. The company reported a Q4 profit after tax of INR 3.98 crore, compared to a loss in the preceding quarter, while full-year EBITDA margins contracted to 6.6% due to cost headwinds and the ramp-up of its Mahad facility. Management has recommended a final dividend of INR 0.50 per share and remains focused on volume growth and efficiency improvements to restore margins.

*this image is generated using AI for illustrative purposes only.
Oriental Aromatics Limited reported a consolidated revenue from operations of INR 1,030.8 crore for the financial year ended March 31, 2026, marking an 11% year-on-year growth. This milestone was achieved despite a challenging external environment characterized by pricing pressure and raw material cost inflation. The Board has recommended a final dividend of INR 0.50 per equity share, subject to shareholder approval at the upcoming Annual General Meeting.
For the fourth quarter of FY26, operating revenue stood at INR 282 crore, reflecting a growth of 12% quarter-on-quarter and 11% year-on-year. EBITDA for the quarter improved to INR 19.5 crore compared to INR 13.2 crore in the previous quarter, with margins expanding to 6.89%. Profit after tax for Q4 FY26 was INR 3.98 crore, recovering from a loss of INR 1.92 crore in the preceding quarter.
Financial Performance
The company's full-year EBITDA declined to INR 68 crore from INR 93.3 crore in FY25, resulting in EBITDA margins of 6.6% compared to 10.06% in the previous year. Profit after tax for FY26 stood at INR 3.3 crore, down from INR 34.3 crore in FY25. The net debt equity ratio as of March 31, 2026, was 0.58x, and the Return on Capital Employed (ROCE) was 4.85%.
| Metric | Q4 FY26 | FY26 |
|---|---|---|
| Operating Revenue | INR 282 crore | INR 1,030.8 crore |
| EBITDA | INR 19.5 crore | INR 68 crore |
| EBITDA Margin | 6.89% | 6.6% |
| Profit After Tax | INR 3.98 crore | INR 3.3 crore |
Operational Highlights
Total sales volume for Q4 FY26 increased by 16% quarter-on-quarter and 5% year-on-year. For the full year, total sales volume grew by 9% over FY25, while production volume increased by 5%. Management attributed the margin compression to a combination of factors, including pricing pressure in the Aroma Ingredients division, rising raw material costs, currency depreciation, and the drag from the Mahad facility ramp-up.
The Mahad facility, operated by Oriental Aromatics & Sons Limited, continues to be in the ramp-up phase and is currently impacting consolidated EBITDA margins by 1% to 1.5%. Management expects the plant to achieve EBITDA neutrality at a utilization level of 75% to 80% within the next year. The facility is anticipated to add approximately INR 60 crore to INR 65 crore in revenue at optimum utilization.
Outlook
Management noted that input costs, particularly for gum turpentine, CST, and alpha-pinene, are at all-time highs. While the company has implemented price increases of 25% to 27% to mitigate these costs, the buyer's market has led to resistance. The company remains focused on volume growth, market share expansion, and internal efficiency programs to rebuild margins structurally.
Historical Stock Returns for Oriental Aromatics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.89% | +5.58% | +7.85% | +16.61% | -13.34% | -58.47% |
How will the company sustain profitability if buyer resistance prevents the full pass-through of recent price hikes?
What specific efficiency programs is management implementing to structurally rebuild margins amidst rising input costs?
What is the expected timeline for the Mahad facility to reach the 75-80% utilization level required for EBITDA neutrality?


































